Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Berger

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|March 22, 2013
Time to raise the standards for FANSLynne Jacoby, Brian Berger
Journal of Palliative Medicine|September 12, 2013
A Canadian experience of integrating complementary therapy in a hospital palliative care unitLiora Berger, Marianne Tavares, Brian Berger
Journal of Palliative Medicine|October 29, 2015
Case Report: Relieving the Itch of Cholestasis with Corticosteroids in Palliative CareLiora Berger, Andrei Garcia Popov, Brian Berger
Retina (Philadelphia, Pa.)|January 16, 2007
Diagnostic and therapeutic challengesClement K Chan, Brian Berger, Brian C Joondeph
Female Pelvic Medicine & Reconstructive Surgery|May 13, 2016
Talk About Sex: Sexual History-Taking Preferences Among Urogynecology Patients and General Gynecology ControlsPamela Susan Fairchild, Jessica Katherine Haefner, Mitchell Brian Berger
Cureus|October 3, 2019
Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk PatientsLance J Lyons, Ethan D Hinds, Sarada Chexal, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Implantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography EvaluationConnor J Ericksen, Cory A Christensen, Brian Berger, et al.
Journal of Vitreoretinal Diseases|November 24, 2025
Exogenous Hormone Use as a Predictor of Central Serous Chorioretinopathy Recurrence: A Comparative Analysis of Observation Versus Low-Fluence Photodynamic TherapyDanny Varghese, Giovanni Campagna, Kevin Elwood, et al.
Translational Vision Science & Technology|December 22, 2021
Safety and Tolerability of Intravitreal Carotuximab (DE-122) in Patients With Persistent Exudative Age-Related Macular Degeneration: A Phase I StudyVictor H Gonzalez, Brian Berger, Roger Goldberg, et al.
Investigative Ophthalmology & Visual Science|May 31, 2018
A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular EdemaJeremy D Gale, Brian Berger, Steven Gilbert, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Healthcare Financial Management : Journal of the Healthcare Financial Management Association|March 22, 2013
Time to raise the standards for FANSLynne Jacoby, Brian Berger
Journal of Palliative Medicine|September 12, 2013
A Canadian experience of integrating complementary therapy in a hospital palliative care unitLiora Berger, Marianne Tavares, Brian Berger
Journal of Palliative Medicine|October 29, 2015
Case Report: Relieving the Itch of Cholestasis with Corticosteroids in Palliative CareLiora Berger, Andrei Garcia Popov, Brian Berger
Retina (Philadelphia, Pa.)|January 16, 2007
Diagnostic and therapeutic challengesClement K Chan, Brian Berger, Brian C Joondeph
Female Pelvic Medicine & Reconstructive Surgery|May 13, 2016
Talk About Sex: Sexual History-Taking Preferences Among Urogynecology Patients and General Gynecology ControlsPamela Susan Fairchild, Jessica Katherine Haefner, Mitchell Brian Berger
Cureus|October 3, 2019
Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk PatientsLance J Lyons, Ethan D Hinds, Sarada Chexal, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Implantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography EvaluationConnor J Ericksen, Cory A Christensen, Brian Berger, et al.
Journal of Vitreoretinal Diseases|November 24, 2025
Exogenous Hormone Use as a Predictor of Central Serous Chorioretinopathy Recurrence: A Comparative Analysis of Observation Versus Low-Fluence Photodynamic TherapyDanny Varghese, Giovanni Campagna, Kevin Elwood, et al.
Translational Vision Science & Technology|December 22, 2021
Safety and Tolerability of Intravitreal Carotuximab (DE-122) in Patients With Persistent Exudative Age-Related Macular Degeneration: A Phase I StudyVictor H Gonzalez, Brian Berger, Roger Goldberg, et al.
Investigative Ophthalmology & Visual Science|May 31, 2018
A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular EdemaJeremy D Gale, Brian Berger, Steven Gilbert, et al.
Pageof 3